Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-26 @ 12:41 AM
Study NCT ID:
NCT01246960
Status:
COMPLETED
Last Update Posted:
2014-10-08
First Post:
2010-11-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
14057
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None